Overview
Lotus AI builds an AI-powered platform for product teams that turns customer feedback into ready-to-use features. It centralizes and analyzes user input, removing manual data work, and uses AI to translate insights and requests directly into development tasks. This lets teams skip guesswork and prioritize features that actually impact user retention, moving faster with a roadmap aligned to real user needs. Compared with traditional product-management tools, Lotus AI automates the end-to-end flow from feedback to deployable feature, enabling faster delivery and more confident decisions. The company aims to help teams achieve higher product velocity and market relevance by focusing development on high-impact work.
Work here?Claim your company
Simplify's take
What believers are saying
- Lotus launched research showing physician agreement with AI-suggested care actions on May 12, 2026.
- Fresh capital supports infrastructure, clinical hiring, and a free model for millions.
- Real physicians reviewing care lowers trust barriers versus fully automated chatbot competitors.
What critics are saying
- The company markets itself as an AI doctor, inviting FDA, malpractice, and advertising scrutiny.
- Physician review still makes Lotus expensive, slowing margins and national scaling.
- A state medical board crackdown can halt prescriptions and kill the platform.
What makes Lotus AI unique
- Lotus AI bundles symptom reasoning, care plans, prescriptions, and physician escalation in one flow.
- It supports 50+ languages and syncs records, labs, medications, wearables, and benefits.
- Kleiner Perkins and CRV backed Lotus's $41M raise on February 3, 2026.
Help us improve and share your feedback! Did you find this helpful?